Sunovion Pharmaceuticals acquires Cynapsus for $653m

26-10-2016

Sunovion Pharmaceuticals acquires Cynapsus for $653m

Rawpixel.com / Shutterstock, Inc

Japanese company Sumitomo Dainippon Pharma’s US subsidiary, Sunovion Pharmaceuticals, has completed the acquisition of Cynapsus Therapeutics.


Sunovion, Sumitomo Dainippon Pharma, Cynapsus, mergers and acquisition, Parkinson’s disease

LSIPR